When is patient transfer considered for the treatment of mold allergies?

Updated: Sep 18, 2017
  • Author: Shih-Wen Huang, MD; Chief Editor: Harumi Jyonouchi, MD  more...
  • Print
Answer

Patients with allergic rhinitis and/or conjunctivitis, AFS, or allergic asthma do not require transfer.

Patients with ABPA, ABPM, or EAA, because of the relapsing nature of these diseases and their propensity to advance to a chronic stage in a subset of patients, may require transfer to a tertiary care medical center, in part for easy access to diagnostic procedures and greater expertise in dealing with these conditions.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!